Talampanel as add-on therapy for the treatment of refractory partial epilepsy

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Child health > Neurology > Epilepsy: drugs for broad populations

Neurology > Epilepsy > Drugs for broad populations

Published:

28 June 2021

Authors:

Cao Y, Zheng J, Zhou Q

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Cao Y, Zheng J, Zhou Q. Talampanel as add-on therapy for the treatment of refractory partial epilepsy (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No.: CD010831. DOI: 10.1002/14651858.CD010831.pub2.